EPALRESTAT 150MG SUSTAINED RELEASE TABLETS
Product Name |
EPALRESTAT 150MG SUSTAINED RELEASE TABLETS |
Packing |
10 X 10 Tablets |
Available strength |
150MG |
Epalrestat is an aldose reductase inhibitor. It blocks the accumulation of sorbitol in cells, which has been related to causing diabetic nerve disease.